ES2299715T3 - Procedimientos de produccion de virus. - Google Patents

Procedimientos de produccion de virus. Download PDF

Info

Publication number
ES2299715T3
ES2299715T3 ES03746051T ES03746051T ES2299715T3 ES 2299715 T3 ES2299715 T3 ES 2299715T3 ES 03746051 T ES03746051 T ES 03746051T ES 03746051 T ES03746051 T ES 03746051T ES 2299715 T3 ES2299715 T3 ES 2299715T3
Authority
ES
Spain
Prior art keywords
temperature
virus
cells
cell
adenovirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES03746051T
Other languages
English (en)
Spanish (es)
Inventor
Liangzhi Xie
Charles F. Goochee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of ES2299715T3 publication Critical patent/ES2299715T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10351—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES03746051T 2002-03-29 2003-03-27 Procedimientos de produccion de virus. Expired - Lifetime ES2299715T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36865402P 2002-03-29 2002-03-29
US368654P 2002-03-29

Publications (1)

Publication Number Publication Date
ES2299715T3 true ES2299715T3 (es) 2008-06-01

Family

ID=28791896

Family Applications (1)

Application Number Title Priority Date Filing Date
ES03746051T Expired - Lifetime ES2299715T3 (es) 2002-03-29 2003-03-27 Procedimientos de produccion de virus.

Country Status (9)

Country Link
US (1) US7344873B2 (enExample)
EP (1) EP1492891B1 (enExample)
JP (1) JP4413012B2 (enExample)
AT (1) ATE386824T1 (enExample)
AU (1) AU2003226012B2 (enExample)
CA (1) CA2478901A1 (enExample)
DE (1) DE60319210T2 (enExample)
ES (1) ES2299715T3 (enExample)
WO (1) WO2003085138A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8426124B2 (en) * 2007-05-04 2013-04-23 Baxter International Inc. Two-step temperature profile for the propagation of viruses
WO2011130119A2 (en) 2010-04-14 2011-10-20 Millipore Corporation Methods of producing high titer, high purity virus stocks and methods of use thereof
US20110262965A1 (en) 2010-04-23 2011-10-27 Life Technologies Corporation Cell culture medium comprising small peptides
US9879229B2 (en) 2011-03-14 2018-01-30 National Research Council Of Canada Method of viral production in cells

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3962424A (en) * 1974-01-31 1976-06-08 Recherche Et Industrie Therapeutiques (R.I.T.) Live brovine adenovirus vaccines, preparation thereof and method of vaccination using them
US5618714A (en) 1993-12-15 1997-04-08 Eli Lilly And Company Methods for producing protein C
US5837520A (en) * 1995-03-07 1998-11-17 Canji, Inc. Method of purification of viral vectors
DE69638058D1 (de) * 1995-06-15 2009-11-26 Crucell Holland Bv Verpackungssysteme für humane rekombinante Adenoviren zur Gentherapie
CA2378539A1 (en) 1999-07-06 2001-01-11 Merck & Co., Inc. Adenovirus carrying gag gene hiv vaccine
CA2422882A1 (en) 2000-09-15 2002-03-21 Merck & Co., Inc. Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications

Also Published As

Publication number Publication date
US7344873B2 (en) 2008-03-18
US20050176146A1 (en) 2005-08-11
EP1492891B1 (en) 2008-02-20
JP4413012B2 (ja) 2010-02-10
AU2003226012A1 (en) 2003-10-20
DE60319210T2 (de) 2009-02-12
EP1492891A4 (en) 2005-08-24
EP1492891A1 (en) 2005-01-05
JP2005521423A (ja) 2005-07-21
CA2478901A1 (en) 2003-10-16
WO2003085138A1 (en) 2003-10-16
AU2003226012B2 (en) 2007-05-24
ATE386824T1 (de) 2008-03-15
DE60319210D1 (de) 2008-04-03

Similar Documents

Publication Publication Date Title
ES2578514T3 (es) Método para la producción de vectores adenovíricos
ES2532015T3 (es) Método para la producción de vectores adenovíricos
KR102022952B1 (ko) 백시니아 바이러스의 생산을 위한 방법 및 조성물
BR112020008435A2 (pt) vetores de adenovírus e seus usos
JP5960120B2 (ja) ウイルス粒子の安定化
Jordan et al. Matrix and backstage: cellular substrates for viral vaccines
ES2257861T3 (es) Procedimiento de produccion viral.
WO2023092863A1 (zh) 一种非洲猪瘟病毒asfv基因的重组病毒组合及由其制备的疫苗
CN103266091A (zh) A型口蹄疫重组疫苗株及其制备方法和应用
CN111356466B (zh) 腺病毒及其用途
Chen et al. Construction of a full-length infectious bacterial artificial chromosome clone of duck enteritis virus vaccine strain
JP7718699B2 (ja) ウイルスの生産方法及び採取用溶液組成物
Sun et al. Development and evaluation of an inactivated coxsackievirus A16 vaccine in gerbils
Mattos et al. Increasing Vero viable cell densities for yellow fever virus production in stirred-tank bioreactors using serum-free medium
ES2299715T3 (es) Procedimientos de produccion de virus.
CN100425291C (zh) O型口蹄疫病毒多基因复制缺陷型腺病毒活载体疫苗及制备方法
CN105713866A (zh) 人巨细胞病毒感染性克隆及其构建方法和应用
WO2021197507A1 (zh) 重组新城疫病毒及制备方法、重组质粒、及其应用
Trabelsi et al. Development of an efficient veterinary rabies vaccine production process in the avian suspension cell line AGE1. CR. pIX
RU2507257C1 (ru) Рекомбинантная псевдоаденовирусная частица на основе генома аденовируса человека 5 серотипа для индукции специфического иммунитета к вирусу гриппа а субтипа н1n1 и способ ее использования в качестве компонента для создания вакцины
Vos et al. Attenuated vaccines for veterinary use
CN110484515B (zh) 一种预防FAdV-4和NDV的疫苗载体及其制备方法及应用
CN1231598C (zh) 一种重组禽腺病毒的制备方法
RU2306336C2 (ru) ШТАММ virus hepatitis A hominis ДЛЯ ПРИГОТОВЛЕНИЯ ВАКЦИННЫХ И ДИАГНОСТИЧЕСКИХ ПРЕПАРАТОВ
Chavda et al. Manufacturing and Control of Viral‐Vector Vaccines: Challenges